Inna Chervoneva

TitleProfessor
InstitutionThomas Jefferson University
DepartmentPharmacology and Exp Therapeut
Address1015 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Temple University, Philadelphia, PA PhD2003Statistics

    Collapse Overview 
    Collapse overview
    Dr. Chervoneva has broad background in design and statistical analysis of clinical, translational and basic science studies and more than 20 years of experience in cancer research, in design and statistical analysis of clinical and translational studies. Dr. Chervoneva is a full member of Jefferson’s NCI-designated Kimmel Cancer Center and serves as a Member of the Cancer Biomarkers Study Section (CBSS) and as a Statistical Representative on the NCI’s Symptom Management and Health-related Quality of Life Steering Committee (SxQoL SC).
    Dr. Chervoneva made contributions to the development of robust methods for linear mixed effects models and density estimation and developed semiparametric mixed effects models for multilevel clustered non-Gaussian data. Dr. Chervoneva’s current research interests focus on statistical methods for discovery and quantification of cancer biomarkers using immunofluorescence-based immunohistochemistry and Next-Generation Sequencing. She develops novel statistical approaches tailored to unmet needs of advanced technologies in biomedical sciences. Dr. Chervoneva’s main collaborations are in clinical oncology, cancer biomarkers, pathology, neurology, traumatic brain injury rehabilitation, and pediatrics.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hills N, Leslie M, Davis R, Crowell M, Kameyama H, Rui H, Chervoneva I, Dooley W, Tanaka T. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma. Ann Surg Oncol. 2021 Mar 21. PMID: 33748899.
      Citations:    
    2. Hills N, Leslie M, Davis R, Crowell M, Kamemyama H, Rui H, Chervoneva I, Dooley W, Tanaka T. ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter? Ann Surg Oncol. 2021 Mar 05. PMID: 33666812.
      Citations:    
    3. Chervoneva I, Peck AR, Yi M, Freydin B, Rui H. Quantification of spatial tumor heterogeneity in immunohistochemistry staining images. Bioinformatics. 2020 Dec 04. PMID: 33275142.
      Citations:    
    4. Teh JLF, Erkes DA, Cheng PF, Tiago M, Wilski NA, Field CO, Chervoneva I, Levesque MP, Xu X, Dummer R, Aplin AE. Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors. Cancer Immunol Res. 2020 Sep; 8(9):1114-1121. PMID: 32661093.
      Citations:    
    5. Rabinowitz AR, Chervoneva I, Hart T, O'Neil-Pirozzi TM, Juengst SB, Hoffman JM. Heterogeneity in Temporal Ordering of Depression and Participation After Traumatic Brain Injury. Arch Phys Med Rehabil. 2020 Jul 10. PMID: 32653581.
      Citations:    
    6. Nguyen MQ, Teh JLF, Purwin TJ, Chervoneva I, Davies MA, Nathanson KL, Cheng PF, Levesque MP, Dummer R, Aplin AE. Targeting PHGDH upregulation reduces glutathione levels and re-sensitizes resistant NRAS mutant melanoma to MEK inhibition. J Invest Dermatol. 2020 May 07. PMID: 32389536.
      Citations:    
    7. Boelig RC, Naert MN, Fox NS, Hennessy S, Chervoneva I, Berghella V, Roman A. Predictors of Early Preterm Birth Despite Vaginal Progesterone Therapy in Singletons with Short Cervix. Am J Perinatol. 2020 Apr 28. PMID: 32344443.
      Citations:    
    8. Huang D, Chervoneva I, Babinsky L, Hurwitz MD. Application of Forcing Functions to Electronic Health Records Is Associated With Improved Pain Control for Patients Undergoing Radiation Therapy for Bone Metastases. Am J Med Qual. 2020 Apr 24; 1062860619900791. PMID: 32326726.
      Citations:    
    9. Song A, Bar-Ad V, Martinez N, Glass J, Andrews DW, Judy K, Evans JJ, Farrell CJ, Werner-Wasik M, Chervoneva I, Ly M, Palmer JD, Liu H, Shi W. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma. J Neurooncol. 2020 Mar 23. PMID: 32206976.
      Citations:    
    10. Morita Y, Leslie M, Kameyama H, Lokesh GLR, Ichimura N, Davis R, Hills N, Hasan N, Zhang R, Kondo Y, Gorenstein DG, Volk DE, Chervoneva I, Rui H, Tanaka T. Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer. Cancers (Basel). 2020 Mar 19; 12(3). PMID: 32204492.
      Citations:    
    11. Rabinowitz AR, Chervoneva I, Hart T, O'Neil-Pirozzi TM, Bogner J, Dams-O'Connor K, Brown AW, Johnson-Greene D. Influence of Prior and Intercurrent Brain Injury on 5-Year Outcome Trajectories After Moderate to Severe Traumatic Brain Injury. J Head Trauma Rehabil. 2020 Jan 28. PMID: 31996607.
      Citations:    
    12. Rosenbaum SR, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue PA, Chervoneva I, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin AE. FOXD3 Regulates VISTA Expression in Melanoma. Cell Rep. 2020 Jan 14; 30(2):510-524.e6. PMID: 31940493.
      Citations:    
    13. Seedor RS, Eschelman DJ, Gonsalves CF, Adamo RD, Orloff M, Amjad A, Sharpe-Mills E, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T. An Outcome Assessment of a Single Institution's Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis. Cancers (Basel). 2020 Jan 01; 12(1). PMID: 31906411.
      Citations:    
    14. Erkes DA, Rosenbaum SR, Field CO, Chervoneva I, Villanueva J, Aplin AE. PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves BET inhibitor efficacy in melanoma. Pigment Cell Melanoma Res. 2019 Nov 06. PMID: 31696640.
      Citations:    
    15. Hart T, Rabinowitz A, Vaccaro M, Chervoneva I, Wilson J. Behavioral Activation Augmented With Mobile Technology for Depression and Anxiety in Chronic Moderate-Severe Traumatic Brain Injury: Protocol for a Randomized Controlled Trial. Arch Rehabil Res Clin Transl. 2019 Dec; 1(3-4):100027. PMID: 33543057.
      Citations:    
    16. Kemp DM, Weingarten S, Chervoneva I, Marley W. Can Nonsterile Gloves for Dermatologic Procedures Be Cost-Effective without Compromising Infection Rates? Skinmed. 2019; 17(3):155-159. PMID: 31496469.
      Citations:    
    17. Bruce SF, Joshi TV, Chervoneva I, Yi M, Chatterjee-Paer S, Burton ER, Edelson MI, Sorosky JI, Shahin MS. Disparities Among Cervical Cancer Patients Receiving Brachytherapy. Obstet Gynecol. 2019 Sep; 134(3):559-569. PMID: 31403593.
      Citations:    
    18. Gonsalves CF, Eschelman DJ, Adamo RD, Anne PR, Orloff MM, Terai M, Hage AN, Yi M, Chervoneva I, Sato T. A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis. Radiology. 2019 Aug 27; 190199. PMID: 31453767.
      Citations:    
    19. Sanchez IM, Purwin TJ, Chervoneva I, Erkes DA, Nguyen MQ, Davies MA, Nathanson KL, Kemper K, Peeper DS, Aplin AE. In vivo ERK1/2 reporter predictively models response and resistance to combined BRAF and MEK inhibitors in melanoma. Mol Cancer Ther. 2019 Jul 03. PMID: 31270153.
      Citations:    
    20. Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB. N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease. Clin Pharmacol Ther. 2019 Jun 17. PMID: 31206613.
      Citations:    
    21. Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ. Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. Breast Cancer Res Treat. 2019 Aug; 177(1):77-91. PMID: 31165373.
      Citations:    
    22. Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I, Berger AC, Hartsough EJ, Villanueva J, Aplin AE. The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner. Pigment Cell Melanoma Res. 2019 May 07. PMID: 31063649.
      Citations:    
    23. Hartsough EJ, Weiss MB, Heilman SA, Purwin TJ, Kugel CH, Rosenbaum SR, Erkes DA, Tiago M, HooKim K, Chervoneva I, Aplin AE. CADM1 is a TWIST1-regulated suppressor of invasion and survival. Cell Death Dis. 2019 Mar 25; 10(4):281. PMID: 30911007.
      Citations:    
    24. Hart T, Vaccaro M, Collier G, Chervoneva I, Fann JR. Promoting mental health in traumatic brain injury using single-session Behavioural Activation and SMS messaging: A randomized controlled trial. Neuropsychol Rehabil. 2019 Mar 14; 1-20. PMID: 30870102.
      Citations:    
    25. Campling BG, Ye Z, Lai Y, Li L, Bar-Ad V, Werner-Wasik M, Lu B, Cowan SW, Evans NR, Chervoneva I, Wang C. Disparity in age at lung cancer diagnosis between current and former smokers. J Cancer Res Clin Oncol. 2019 Mar 04. PMID: 30830294.
      Citations:    
    26. Hossain C, Jennings T, Duffy R, Knoblauch K, Gochoco A, Chervoneva I, Shi W, Alpdogan SO, Porcu P, Pro B, Sahu J. The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides. Chin Clin Oncol. 2019 Feb; 8(1):6. PMID: 30818957.
      Citations:    
    27. Nikbakht N, Tiago M, Erkes DA, Chervoneva I, Aplin AE. BET inhibition modifies melanoma infiltrating T cells and enhances response to PD-L1 blockade. J Invest Dermatol. 2019 Jan 28. PMID: 30703359.
      Citations:    
    28. Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. Eur J Cancer. 2019 Jan; 106:133-143. PMID: 30528798.
      Citations:    
    29. Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms. Cancer Discov. 2018 Dec; 8(12):1654. PMID: 30510016.
      Citations:    
    30. Mintzer S, Trinka E, Kraemer G, Chervoneva I, Werhahn KJ. Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly. Epilepsia. 2018 Oct; 59(10):1899-1907. PMID: 30178473.
      Citations:    
    31. Capparelli C, Purwin TJ, Heilman SA, Chervoneva I, McCue PA, Berger AC, Davies MA, Gershenwald JE, Krepler C, Aplin AE. ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma. Cancer Res. 2018 Oct 01; 78(19):5680-5693. PMID: 30115691.
      Citations:    
    32. Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling. Clin Cancer Res. 2018 Aug 10. PMID: 30097435.
      Citations:    
    33. Weiss SA, Berry B, Chervoneva I, Waldman Z, Guba J, Bower M, Kucewicz M, Brinkmann B, Kremen V, Khadjevand F, Varatharajah Y, Guragain H, Sharan A, Wu C, Staba R, Engel J, Sperling M, Worrell G. Visually validated semi-automatic high-frequency oscillation detection aides the delineation of epileptogenic regions during intra-operative electrocorticography. Clin Neurophysiol. 2018 Oct; 129(10):2089-2098. PMID: 30077870.
      Citations:    
    34. Bashir B, Stickle DF, Chervoneva I, Kraft WK. Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers. Clin Transl Sci. 2018 Jul 03. PMID: 29972633.
      Citations:    
    35. Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. In vivo E2F reporting reveals efficacious schedules of MEK1/2-CDK4/6 targeting and mTOR-S6 resistance mechanisms. Cancer Discov. 2018 Mar 01. PMID: 29496664.
      Citations:    
    36. Monti DA, Tobia A, Stoner M, Wintering N, Matthews M, Conklin CJ, Mohamed FB, Chervoneva I, Newberg AB. Changes in cerebellar functional connectivity and autonomic regulation in cancer patients treated with the Neuro Emotional Technique for traumatic stress symptoms. J Cancer Surviv. 2018 Feb; 12(1):145-153. PMID: 29052102.
      Citations:    
    37. Hauzenberger JR, Hipszer BR, Loeum C, McCue PA, DeStefano M, Torjman MC, Kaner MT, Dinesen AR, Chervoneva I, Pieber TR, Joseph JI. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine. Diabetes Technol Ther. 2017 Nov; 19(11):641-650. PMID: 28981324.
      Citations:    
    38. Song I, Orosz I, Chervoneva I, Waldman ZJ, Fried I, Wu C, Sharan A, Salamon N, Gorniak R, Dewar S, Bragin A, Engel J, Sperling MR, Staba R, Weiss SA. Bimodal coupling of ripples and slower oscillations during sleep in patients with focal epilepsy. Epilepsia. 2017 11; 58(11):1972-1984. PMID: 28948998.
      Citations:    
    39. Valsecchi ME, Orloff M, Sato R, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls. Ophthalmology. 2018 Feb; 125(2):210-217. PMID: 28935400.
      Citations:    
    40. Hart T, Whyte J, Watanabe T, Chervoneva I. Effects of dextroamphetamine in subacute traumatic brain injury: A randomized, placebo-controlled pilot study. J Neurosci Res. 2017 Jun 27. PMID: 28653428.
      Citations:    
    41. Morita Y, Zhang R, Leslie M, Adhikari S, Hasan N, Chervoneva I, Rui H, Tanaka T. Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas. Oncol Lett. 2017 Aug; 14(2):2111-2118. PMID: 28789438.
      Citations:    
    42. Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, Ehrlich ME. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome. N Engl J Med. 2017 06 15; 376(24):2341-2348. PMID: 28468518.
      Citations:    
    43. Telonis AG, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res. 2017 Apr 07; 45(6):2973-2985. PMID: 28206648.
      Citations:    
    44. Monti DA, Tobia A, Stoner M, Wintering N, Matthews M, He XS, Doucet G, Chervoneva I, Tracy JI, Newberg AB. Neuro emotional technique effects on brain physiology in cancer patients with traumatic stress symptoms: preliminary findings. J Cancer Surviv. 2017 Aug; 11(4):438-446. PMID: 28181091.
      Citations:    
    45. Chervoneva I, Freydin B, Hyslop T, Waldman SA. Modeling qRT-PCR dynamics with application to cancer biomarker quantification. Stat Methods Med Res. 2017 Jan 01; 962280216683204. PMID: 28504051.
      Citations:    
    46. Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer. Breast Cancer Res Treat. 2017 Jan; 161(1):83-94. PMID: 27771841.
      Citations:    
    47. Teh JL, Purwin TJ, Greenawalt EJ, Chervoneva I, Goldberg A, Davies MA, Aplin AE. An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma. Cancer Res. 2016 Sep 15; 76(18):5455-66. PMID: 27488531.
      Citations:    
    48. Hart T, Whyte J, Poulsen I, Kristensen KS, Nordenbo AM, Chervoneva I, Vaccaro MJ. How Do Intensity and Duration of Rehabilitation Services Affect Outcomes From Severe Traumatic Brain Injury? A Natural Experiment Comparing Health Care Delivery Systems in 2 Developed Nations. Arch Phys Med Rehabil. 2016 Aug 3. PMID: 27497825.
      Citations:    
    49. Yang J, Wu C, Stefanescu I, Jakobsson L, Chervoneva I, Horowitz A. RhoA inhibits neural differentiation in murine stem cells through multiple mechanisms. Sci Signal. 2016; 9(438):ra76. PMID: 27460990.
      Citations:    
    50. Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms. Mod Pathol. 2016 Oct; 29(10):1143-54. PMID: 27312066.
      Citations:    
    51. Oppong YD, Farber JL, Chervoneva I, Martinez Cantarin MP. Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes. Clin Transplant. 2016 Jul; 30(7):836-44. PMID: 27146243.
      Citations:    
    52. Mintzer S, Miller R, Shah K, Chervoneva I, Nei M, Skidmore C, Sperling MR. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. Epilepsy Behav. 2016 May; 58:127-32. PMID: 27074299.
      Citations:    
    53. Salem I, Alsalahi M, Chervoneva I, Aburto LD, Addya S, Ott GR, Ruggeri BA, Cristofanilli M, Fernandez SV. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells. Breast Cancer Res. 2016; 18(1):37. PMID: 27009091.
      Citations:    
    54. Li Y, Raghavarao D, Chervoneva I. Extensions of D-optimal Minimal Designs for Symmetric Mixture Models. Commun Stat Theory Methods. 2017; 46(5):2542-2558. PMID: 29081574.
      Citations:    
    55. Valentino MA, Chervoneva I, Diemer GA. Changes in the preferences of US physicians-in-training for medical interventions throughout medical education. Med Educ. 2016 Feb; 50(2):214-24. PMID: 26813000.
      Citations:    
    56. Hart T, Fann JR, Chervoneva I, Juengst SB, Rosenthal JA, Krellman JW, Dreer LE, Kroenke K. Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year After Moderate to Severe Traumatic Brain Injury. Arch Phys Med Rehabil. 2016 May; 97(5):701-7. PMID: 26707456.
      Citations:    
    57. Terai M, Mu Z, Eschelman DJ, Gonsalves CF, Kageyama K, Chervoneva I, Orloff M, Weight R, Mastrangelo MJ, Cristofanilli M, Sato T. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells. EBioMedicine. 2015 Nov; 2(11):1821-6. PMID: 26870807.
      Citations:    
    58. Capparelli C, Rosenbaum S, Berman-Booty LD, Salhi A, Gaborit N, Zhan T, Chervoneva I, Roszik J, Woodman SE, Davies MA, Setiady YY, Osman I, Yarden Y, Aplin AE. ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas. Cancer Res. 2015 Sep 1; 75(17):3554-67. PMID: 26206558.
      Citations:    
    59. Valsecchi ME, Terai M, Eschelman DJ, Gonsalves CF, Chervoneva I, Shields JA, Shields CL, Yamamoto A, Sullivan KL, Laudadio M, Berd D, Mastrangelo MJ, Sato T. Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte-Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases. J Vasc Interv Radiol. 2015 Apr; 26(4):523-532.e2. PMID: 25678394.
      Citations:    
    60. Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N. A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease. Biol Blood Marrow Transplant. 2015 Apr; 21(4):646-52. PMID: 25542159.
      Citations:    
    61. Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK. A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA. Am J Cancer Ther Pharmacol. 2014 Sep 7; 2(1):21-32. PMID: 25580468.
      Citations:    
    62. Xu Y, Iglewicz B, Chervoneva I. Robust Estimation of the Parameters of g - and - h Distributions, with Applications to Outlier Detection. Comput Stat Data Anal. 2014 Jul 1; 75:66-80. PMID: 24665144.
      Citations:    
    63. Chervoneva I, Freydin B, Hipszer B, Apanasovich TV, Joseph JI. Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothing. Ann Appl Stat. 2014 Jun; 8(2):886-904. PMID: 33833847.
      Citations:    
    64. Mraovic B, Hipszer BR, Epstein RH, Parvizi J, Pequignot EC, Chervoneva I, Joseph JI. Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty. Croat Med J. 2013 Aug 28; 54(4):355-61. PMID: 23986276.
      Citations:    
    65. Hart T, Brockway JA, Whyte J, Bell KR, Neuberger S, Chervoneva I. Analyzing the ingredients of a telephone counseling intervention for traumatic brain injury. Disabil Rehabil. 2013 Sep; 35(19):1668-75. PMID: 23336123.
      Citations:    
    66. Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H. Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. Breast Cancer Res. 2013; 15(5):R73. PMID: 24004716.
      Citations:    
    67. Chervoneva I, Zhan T, Iglewicz B, Hauck WW, Birk DE. Two-stage hierarchical modeling for analysis of subpopulations in conditional distributions. J Appl Stat. 2012; 39(2):445-460. PMID: 22523443.
      Citations:    
    68. Mintzer S, Skidmore CT, Rankin SJ, Chervoneva I, Pequinot E, Capuzzi DM, Sperling MR. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Epilepsy Res. 2012 Jan; 98(1):88-93. PMID: 22119637.
      Citations:    
    69. Hart T, Brenner L, Clark AN, Bogner JA, Novack TA, Chervoneva I, Nakase-Richardson R, Arango-Lasprilla JC. Major and minor depression after traumatic brain injury. Arch Phys Med Rehabil. 2011 Aug; 92(8):1211-9. PMID: 21807140.
      Citations:    
    70. Showalter TN, Zhan T, Anne PR, Chervoneva I, Mitchell EP, Yeo CJ, Rosato EL, Kennedy EP, Berger AC. The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. J Gastrointest Surg. 2011 Aug; 15(8):1411-6. PMID: 21523621.
      Citations:    
    71. Mahipal A, Terai M, Berd D, Chervoneva I, Patel K, Mastrangelo MJ, Sato T. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer Immunol Immunother. 2011 Jul; 60(7):1039-45. PMID: 21519827.
      Citations:    
    72. Holmes P, Lloyd J, Chervoneva I, Pequinot E, Cornfield DB, Schwartz GF, Allen KG, Palazzo JP. Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone. Cancer. 2011 Aug 15; 117(16):3650-7. PMID: 21319154.
      Citations:    
    73. Chervoneva I, Vishnyakov M. Constrained S-estimators for linear mixed effects models with covariance components. Stat Med. 2011 Jun 30; 30(14):1735-50. PMID: 21638300.
      Citations:    
    74. Behling KC, Tang A, Freydin B, Chervoneva I, Kadakia S, Schwartz GF, Rui H, Witkiewicz AK. Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma. Breast Cancer Res Treat. 2011 Oct; 129(3):717-24. PMID: 21088888.
      Citations:    
    75. Buckingham SE, Chervoneva I, Sharan A, Zangaladze A, Mintzer S, Skidmore C, Nei M, Evans J, Pequignot E, Sperling MR. Latency to first seizure after temporal lobectomy predicts long-term outcome. Epilepsia. 2010 Oct; 51(10):1987-93. PMID: 21069902.
      Citations:    
    76. Witkiewicz AK, Freydin B, Chervoneva I, Potoczek M, Rizzo W, Rui H, Brody JR, Schwartz GF, Lisanti MP. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence. Cancer Biol Ther. 2010 Aug; 10(4):391-6. PMID: 20574156.
      Citations:    
    77. Chervoneva I, Li Y, Schulz S, Croker S, Wilson C, Waldman SA, Hyslop T. Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics. 2010; 11:253. PMID: 20470420.
      Citations:    
    78. Valicenti RK, Trabulsi E, Intenzo C, Lavarino J, Xu Y, Chervoneva I. A Phase I trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: first report of a completed study. Int J Radiat Oncol Biol Phys. 2011 Mar 1; 79(3):732-7. PMID: 20399029.
      Citations:    
    79. Hart T, Whyte J, Ellis C, Chervoneva I. Construct validity of an attention rating scale for traumatic brain injury. Neuropsychology. 2009 Nov; 23(6):729-35. PMID: 19899831.
      Citations:    
    80. Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol. 2009 Nov; 3(6):1309-18. PMID: 20144385.
      Citations:    
    81. Faul EJ, Aye PP, Papaneri AB, Pahar B, McGettigan JP, Schiro F, Chervoneva I, Montefiori DC, Lackner AA, Schnell MJ. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge. Vaccine. 2009 Dec 11; 28(2):299-308. PMID: 19879223.
      Citations:    
    82. Yamamoto A, Chervoneva I, Sullivan KL, Eschelman DJ, Gonsalves CF, Mastrangelo MJ, Berd D, Shields JA, Shields CL, Terai M, Sato T. High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma. Radiology. 2009 Jul; 252(1):290-8. PMID: 19561263.
      Citations:    
    83. Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, Sperling MR. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol. 2009 Apr; 65(4):448-56. PMID: 19296463.
      Citations:    
    84. Sato T, Eschelman DJ, Gonsalves CF, Terai M, Chervoneva I, McCue PA, Shields JA, Shields CL, Yamamoto A, Berd D, Mastrangelo MJ, Sullivan KL. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. J Clin Oncol. 2008 Nov 20; 26(33):5436-42. PMID: 18838710.
      Citations:    
    85. Zuzga DS, Gibbons AV, Li P, Lubbe WJ, Chervoneva I, Pitari GM. Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis. Clin Transl Sci. 2008 Sep; 1(2):136-41. PMID: 20443834.
      Citations:    
    86. Reigle KL, Di Lullo G, Turner KR, Last JA, Chervoneva I, Birk DE, Funderburgh JL, Elrod E, Germann MW, Surber C, Sanderson RD, San Antonio JD. Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion. J Cell Biochem. 2008 Aug 1; 104(5):1684-98. PMID: 18348167.
      Citations:    
    87. Whyte J, Hart T, Ellis CA, Chervoneva I. The Moss Attention Rating Scale for traumatic brain injury: further explorations of reliability and sensitivity to change. Arch Phys Med Rehabil. 2008 May; 89(5):966-73. PMID: 18452747.
      Citations:    
    88. Chervoneva I, Li Y, Iglewicz B, Waldman S, Hyslop T. Relative quantification based on logistic models for individual polymerase chain reactions. Stat Med. 2007 Dec 30; 26(30):5596-611. PMID: 17968873.
      Citations:    
    89. Li P, Lin JE, Chervoneva I, Schulz S, Waldman SA, Pitari GM. Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. Am J Pathol. 2007 Dec; 171(6):1847-58. PMID: 17974601.
      Citations:    
    90. Zangaladze A, Sharan A, Evans J, Wyeth DH, Wyeth EG, Tracy JI, Chervoneva I, Sperling MR. The effectiveness of low-frequency stimulation for mapping cortical function. Epilepsia. 2008 Mar; 49(3):481-7. PMID: 17868054.
      Citations:    
    91. Wilson M, Rosato EL, Chojnacki KA, Chervoneva I, Kairys JC, Cohn HE, Rosato FE, Berger AC. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res. 2008 May 1; 146(1):11-5. PMID: 18028955.
      Citations:    
    92. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy. 2007 May; 27(5):691-6. PMID: 17461704.
      Citations:    
    93. Chervoneva I, Hyslop T, Hauck WW. A multivariate test for population bioequivalence. Stat Med. 2007 Mar 15; 26(6):1208-23. PMID: 16810712.
      Citations:    
    94. Chervoneva I, Iglewicz B, Hyslop T. A general approach for two-stage analysis of multilevel clustered non-Gaussian data. Biometrics. 2006 Sep; 62(3):752-9. PMID: 16984317.
      Citations:    
    95. Chakravarti S, Zhang G, Chervoneva I, Roberts L, Birk DE. Collagen fibril assembly during postnatal development and dysfunctional regulation in the lumican-deficient murine cornea. Dev Dyn. 2006 Sep; 235(9):2493-506. PMID: 16786597.
      Citations:    
    96. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE. Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development. J Cell Biochem. 2006 Aug 15; 98(6):1436-49. PMID: 16518859.
      Citations:    
    97. Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, Domon-Cell C, Palazzo JP, Freund JN, Li P, Pitari GM, Schulz S, Waldman SA. Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology. 2006 Apr; 130(4):1191-206. PMID: 16618413.
      Citations:    
    98. Wenstrup RJ, Florer JB, Davidson JM, Phillips CL, Pfeiffer BJ, Menezes DW, Chervoneva I, Birk DE. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem. 2006 May 5; 281(18):12888-95. PMID: 16492673.
      Citations:    
    99. Segev F, Héon E, Cole WG, Wenstrup RJ, Young F, Slomovic AR, Rootman DS, Whitaker-Menezes D, Chervoneva I, Birk DE. Structural abnormalities of the cornea and lid resulting from collagen V mutations. Invest Ophthalmol Vis Sci. 2006 Feb; 47(2):565-73. PMID: 16431952.
      Citations:    
    100. Chervoneva I, Hyslop T, Iglewicz B, Johns L, Wolfe HR, Schulz S, Leong E, Waldman S. Statistical algorithm for assuring similar efficiency in standards and samples for absolute quantification by real-time reverse transcription polymerase chain reaction. Anal Biochem. 2006 Jan 15; 348(2):198-208. PMID: 16336939.
      Citations:    
    101. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem. 2004 Dec 17; 279(51):53331-7. PMID: 15383546.
      Citations:    
    102. Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer. 2004 Jun 1; 100(11):2317-27. PMID: 15160334.
      Citations:    
    103. Valicenti RK, Chervoneva I, Gomella LG. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1093-7. PMID: 15001249.
      Citations:    
    104. Chakravarti S, Paul J, Roberts L, Chervoneva I, Oldberg A, Birk DE. Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest Ophthalmol Vis Sci. 2003 Jun; 44(6):2422-32. PMID: 12766039.
      Citations:    
    105. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet. 2003 Jun; 72(6):1425-35. PMID: 12721954.
      Citations:    
    106. Berghella V, Haas S, Chervoneva I, Hyslop T. Patients with prior second-trimester loss: prophylactic cerclage or serial transvaginal sonograms? Am J Obstet Gynecol. 2002 Sep; 187(3):747-51. PMID: 12237658.
      Citations:    
    107. Sauter ER, Tichansky DS, Chervoneva I, Diamandis EP. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer. Environ Health Perspect. 2002 Mar; 110(3):241-6. PMID: 11882474.
      Citations:    
    108. Sauter ER, Chervoneva I, Diamandis A, Khosravi JM, Litwin S, Diamandis EP. Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer. Cancer Detect Prev. 2002; 26(2):149-57. PMID: 12102150.
      Citations:    
    Chervoneva's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (343)
    Explore
    _
    Co-Authors (114)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _